We are analyzing https://link.springer.com/article/10.1007/s00415-019-09688-0.

Title:
Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy | Journal of Neurology
Description:
Amyloid transthyretin (ATTR) amyloidosis with polyneuropathy (PN) is a progressive, debilitating, systemic disease wherein transthyretin protein misfolds to form amyloid, which is deposited in the endoneurium. ATTR amyloidosis with PN is the most serious hereditary polyneuropathy of adult onset. It arises from a hereditary mutation in the TTR gene and may involve the heart as well as other organs. It is critical to identify and diagnose the disease earlier because treatments are available to help slow the progression of neuropathy. Early diagnosis is complicated, however, because presentation may vary and family history is not always known. Symptoms may be mistakenly attributed to other diseases such as chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), idiopathic axonal polyneuropathy, lumbar spinal stenosis, and, more rarely, diabetic neuropathy and AL amyloidosis. In endemic countries (e.g., Portugal, Japan, Sweden, Brazil), ATTR amyloidosis with PN should be suspected in any patient who has length-dependent small-fiber PN with autonomic dysfunction and a family history of ATTR amyloidosis, unexplained weight loss, heart rhythm disorders, vitreous opacities, or renal abnormalities. In nonendemic countries, the disease may present as idiopathic rapidly progressive sensory motor axonal neuropathy or atypical CIDP with any of the above symptoms or with bilateral carpal tunnel syndrome, gait disorders, or cardiac hypertrophy. Diagnosis should include DNA testing, biopsy, and amyloid typing. Patients should be followed up every 6–12 months, depending on the severity of the disease and response to therapy. This review outlines detailed recommendations to improve the diagnosis of ATTR amyloidosis with PN.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Health & Fitness
Education
Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't figure out the monetization strategy.

While profit motivates many websites, others exist to inspire, entertain, or provide valuable resources. Websites have a variety of goals. And this might be one of them. Link.springer.com could have a money-making trick up its sleeve, but it's undetectable for now.

Keywords {🔍}

pubmed, amyloidosis, google, scholar, amyloid, polyneuropathy, cas, disease, transthyretin, familial, patients, neuropathy, diagnosis, attrv, adams, cardiac, attr, ttr, biopsy, hereditary, clinical, central, neurol, dysfunction, table, autonomic, ando, symptoms, onset, early, suhr, manifestations, coelho, areas, diagnostic, family, involvement, valmet, nerve, recommendations, merlini, heart, history, peripheral, review, gene, loss, include, type, research,

Topics {✒️}

nt-probnp n-terminal fragment immune-mediated peripheral neuropathies length-dependent small-fiber pn heart [n-terminal fragment hereditary transthyretin-related amyloidosis transthyretin-related hereditary amyloidosis article download pdf idiopathic axonal polyneuropathy transthyretin mis-sense mutation université paris-saclay aphp congo red-stained preparations emerging disease-modifying therapies ttr-related amyloid neuropathy full size table idiopathic progressive neuropathy transthyretin amyloid neuropathies pubmed central sensory motor neuropathy progressive myocardial infiltration mini-invasive biopsy reduced motor skills sensory-motor dysfunction full-length ttr joão melo beirão length-dependent polyneuropathy identifying amyloid neuropathy late-onset attr amyloidosis van rijswijk mh privacy choices/manage cookies include sensory problems hereditary transthyretin amyloidosis van doorn pa familial amyloidotic polyneuropathies familial transthyretin amyloidosis autonomic peripheral neuropathy full access diseases familial amyloid polyneuropathy familial amyloidotic polyneuropathy include dna testing attr amyloid transthyretin peripheral nervous system treatable hereditary neuropathy amyloid fibril composition progressive idiopathic early disease-modifying therapy idiopathic neuropathy expert working group bilateral carpal tunnel abdominal fat aspiration

Questions {❓}

Adams D, Beaudonnet G, Adam C, Lacroix C, Theaudin M, Cauquil C, Labeyrie C (2016) Familial amyloid polyneuropathy: when does it stop to be asymptomatic and need a treatment?
Chance or challenge, spoilt for choice?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy
         description:Amyloid transthyretin (ATTR) amyloidosis with polyneuropathy (PN) is a progressive, debilitating, systemic disease wherein transthyretin protein misfolds to form amyloid, which is deposited in the endoneurium. ATTR amyloidosis with PN is the most serious hereditary polyneuropathy of adult onset. It arises from a hereditary mutation in the TTR gene and may involve the heart as well as other organs. It is critical to identify and diagnose the disease earlier because treatments are available to help slow the progression of neuropathy. Early diagnosis is complicated, however, because presentation may vary and family history is not always known. Symptoms may be mistakenly attributed to other diseases such as chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), idiopathic axonal polyneuropathy, lumbar spinal stenosis, and, more rarely, diabetic neuropathy and AL amyloidosis. In endemic countries (e.g., Portugal, Japan, Sweden, Brazil), ATTR amyloidosis with PN should be suspected in any patient who has length-dependent small-fiber PN with autonomic dysfunction and a family history of ATTR amyloidosis, unexplained weight loss, heart rhythm disorders, vitreous opacities, or renal abnormalities. In nonendemic countries, the disease may present as idiopathic rapidly progressive sensory motor axonal neuropathy or atypical CIDP with any of the above symptoms or with bilateral carpal tunnel syndrome, gait disorders, or cardiac hypertrophy. Diagnosis should include DNA testing, biopsy, and amyloid typing. Patients should be followed up every 6–12 months, depending on the severity of the disease and response to therapy. This review outlines detailed recommendations to improve the diagnosis of ATTR amyloidosis with PN.
         datePublished:2020-01-06T00:00:00Z
         dateModified:2020-01-06T00:00:00Z
         pageStart:2109
         pageEnd:2122
         license:http://creativecommons.org/licenses/by/4.0/
         sameAs:https://doi.org/10.1007/s00415-019-09688-0
         keywords:
            ATTR amyloidosis
            ATTRv
            Diagnosis
            hATTR
            Peripheral neuropathy
            Transthyretin amyloidosis
            Neurology
            Neurosciences
            Neuroradiology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00415-019-09688-0/MediaObjects/415_2019_9688_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00415-019-09688-0/MediaObjects/415_2019_9688_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00415-019-09688-0/MediaObjects/415_2019_9688_Fig3_HTML.png
         isPartOf:
            name:Journal of Neurology
            issn:
               1432-1459
               0340-5354
            volumeNumber:268
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Berlin Heidelberg
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:David Adams
               url:http://orcid.org/0000-0002-8722-4108
               affiliation:
                     name:French National Reference Centre for Familial Amyloidotic Polyneuropathy, CHU Bicêtre, Université Paris-Saclay APHP, INSERM U1195
                     address:
                        name:Department of Neurology, French National Reference Centre for Familial Amyloidotic Polyneuropathy, CHU Bicêtre, Université Paris-Saclay APHP, INSERM U1195, Le Kremlin-Bicêtre, France
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Yukio Ando
               affiliation:
                     name:Graduate School of Medical Sciences
                     address:
                        name:Department of Neurology, Graduate School of Medical Sciences, Kumamoto, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:João Melo Beirão
               affiliation:
                     name:Hospital de Santo António
                     address:
                        name:Ophthalmology Service, Hospital de Santo António, Porto, Portugal
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Teresa Coelho
               affiliation:
                     name:Centro Hospitalar Do Porto
                     address:
                        name:Centro Hospitalar Do Porto, Porto, Portugal
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Morie A. Gertz
               affiliation:
                     name:Mayo Clinic
                     address:
                        name:Mayo Clinic, Rochester, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Julian D. Gillmore
               affiliation:
                     name:University College London
                     address:
                        name:National Amyloidosis Centre, University College London, London, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Philip N. Hawkins
               affiliation:
                     name:University College London
                     address:
                        name:National Amyloidosis Centre, University College London, London, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Isabelle Lousada
               affiliation:
                     name:Amyloidosis Research Consortium
                     address:
                        name:Amyloidosis Research Consortium, Boston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ole B. Suhr
               affiliation:
                     name:Umeå University
                     address:
                        name:Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Giampaolo Merlini
               affiliation:
                     name:IRCCS Policlinico San Matteo
                     address:
                        name:Amyloidosis Center Foundation, IRCCS Policlinico San Matteo, San Matteo, Italy
                        type:PostalAddress
                     type:Organization
                     name:University of Pavia
                     address:
                        name:Department of Molecular Medicine, University of Pavia, Pavia, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy
      description:Amyloid transthyretin (ATTR) amyloidosis with polyneuropathy (PN) is a progressive, debilitating, systemic disease wherein transthyretin protein misfolds to form amyloid, which is deposited in the endoneurium. ATTR amyloidosis with PN is the most serious hereditary polyneuropathy of adult onset. It arises from a hereditary mutation in the TTR gene and may involve the heart as well as other organs. It is critical to identify and diagnose the disease earlier because treatments are available to help slow the progression of neuropathy. Early diagnosis is complicated, however, because presentation may vary and family history is not always known. Symptoms may be mistakenly attributed to other diseases such as chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), idiopathic axonal polyneuropathy, lumbar spinal stenosis, and, more rarely, diabetic neuropathy and AL amyloidosis. In endemic countries (e.g., Portugal, Japan, Sweden, Brazil), ATTR amyloidosis with PN should be suspected in any patient who has length-dependent small-fiber PN with autonomic dysfunction and a family history of ATTR amyloidosis, unexplained weight loss, heart rhythm disorders, vitreous opacities, or renal abnormalities. In nonendemic countries, the disease may present as idiopathic rapidly progressive sensory motor axonal neuropathy or atypical CIDP with any of the above symptoms or with bilateral carpal tunnel syndrome, gait disorders, or cardiac hypertrophy. Diagnosis should include DNA testing, biopsy, and amyloid typing. Patients should be followed up every 6–12 months, depending on the severity of the disease and response to therapy. This review outlines detailed recommendations to improve the diagnosis of ATTR amyloidosis with PN.
      datePublished:2020-01-06T00:00:00Z
      dateModified:2020-01-06T00:00:00Z
      pageStart:2109
      pageEnd:2122
      license:http://creativecommons.org/licenses/by/4.0/
      sameAs:https://doi.org/10.1007/s00415-019-09688-0
      keywords:
         ATTR amyloidosis
         ATTRv
         Diagnosis
         hATTR
         Peripheral neuropathy
         Transthyretin amyloidosis
         Neurology
         Neurosciences
         Neuroradiology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00415-019-09688-0/MediaObjects/415_2019_9688_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00415-019-09688-0/MediaObjects/415_2019_9688_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00415-019-09688-0/MediaObjects/415_2019_9688_Fig3_HTML.png
      isPartOf:
         name:Journal of Neurology
         issn:
            1432-1459
            0340-5354
         volumeNumber:268
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Berlin Heidelberg
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:David Adams
            url:http://orcid.org/0000-0002-8722-4108
            affiliation:
                  name:French National Reference Centre for Familial Amyloidotic Polyneuropathy, CHU Bicêtre, Université Paris-Saclay APHP, INSERM U1195
                  address:
                     name:Department of Neurology, French National Reference Centre for Familial Amyloidotic Polyneuropathy, CHU Bicêtre, Université Paris-Saclay APHP, INSERM U1195, Le Kremlin-Bicêtre, France
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Yukio Ando
            affiliation:
                  name:Graduate School of Medical Sciences
                  address:
                     name:Department of Neurology, Graduate School of Medical Sciences, Kumamoto, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:João Melo Beirão
            affiliation:
                  name:Hospital de Santo António
                  address:
                     name:Ophthalmology Service, Hospital de Santo António, Porto, Portugal
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Teresa Coelho
            affiliation:
                  name:Centro Hospitalar Do Porto
                  address:
                     name:Centro Hospitalar Do Porto, Porto, Portugal
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Morie A. Gertz
            affiliation:
                  name:Mayo Clinic
                  address:
                     name:Mayo Clinic, Rochester, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Julian D. Gillmore
            affiliation:
                  name:University College London
                  address:
                     name:National Amyloidosis Centre, University College London, London, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Philip N. Hawkins
            affiliation:
                  name:University College London
                  address:
                     name:National Amyloidosis Centre, University College London, London, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Isabelle Lousada
            affiliation:
                  name:Amyloidosis Research Consortium
                  address:
                     name:Amyloidosis Research Consortium, Boston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ole B. Suhr
            affiliation:
                  name:Umeå University
                  address:
                     name:Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Giampaolo Merlini
            affiliation:
                  name:IRCCS Policlinico San Matteo
                  address:
                     name:Amyloidosis Center Foundation, IRCCS Policlinico San Matteo, San Matteo, Italy
                     type:PostalAddress
                  type:Organization
                  name:University of Pavia
                  address:
                     name:Department of Molecular Medicine, University of Pavia, Pavia, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Journal of Neurology
      issn:
         1432-1459
         0340-5354
      volumeNumber:268
Organization:
      name:Springer Berlin Heidelberg
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:French National Reference Centre for Familial Amyloidotic Polyneuropathy, CHU Bicêtre, Université Paris-Saclay APHP, INSERM U1195
      address:
         name:Department of Neurology, French National Reference Centre for Familial Amyloidotic Polyneuropathy, CHU Bicêtre, Université Paris-Saclay APHP, INSERM U1195, Le Kremlin-Bicêtre, France
         type:PostalAddress
      name:Graduate School of Medical Sciences
      address:
         name:Department of Neurology, Graduate School of Medical Sciences, Kumamoto, Japan
         type:PostalAddress
      name:Hospital de Santo António
      address:
         name:Ophthalmology Service, Hospital de Santo António, Porto, Portugal
         type:PostalAddress
      name:Centro Hospitalar Do Porto
      address:
         name:Centro Hospitalar Do Porto, Porto, Portugal
         type:PostalAddress
      name:Mayo Clinic
      address:
         name:Mayo Clinic, Rochester, USA
         type:PostalAddress
      name:University College London
      address:
         name:National Amyloidosis Centre, University College London, London, UK
         type:PostalAddress
      name:University College London
      address:
         name:National Amyloidosis Centre, University College London, London, UK
         type:PostalAddress
      name:Amyloidosis Research Consortium
      address:
         name:Amyloidosis Research Consortium, Boston, USA
         type:PostalAddress
      name:Umeå University
      address:
         name:Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden
         type:PostalAddress
      name:IRCCS Policlinico San Matteo
      address:
         name:Amyloidosis Center Foundation, IRCCS Policlinico San Matteo, San Matteo, Italy
         type:PostalAddress
      name:University of Pavia
      address:
         name:Department of Molecular Medicine, University of Pavia, Pavia, Italy
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:David Adams
      url:http://orcid.org/0000-0002-8722-4108
      affiliation:
            name:French National Reference Centre for Familial Amyloidotic Polyneuropathy, CHU Bicêtre, Université Paris-Saclay APHP, INSERM U1195
            address:
               name:Department of Neurology, French National Reference Centre for Familial Amyloidotic Polyneuropathy, CHU Bicêtre, Université Paris-Saclay APHP, INSERM U1195, Le Kremlin-Bicêtre, France
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Yukio Ando
      affiliation:
            name:Graduate School of Medical Sciences
            address:
               name:Department of Neurology, Graduate School of Medical Sciences, Kumamoto, Japan
               type:PostalAddress
            type:Organization
      name:João Melo Beirão
      affiliation:
            name:Hospital de Santo António
            address:
               name:Ophthalmology Service, Hospital de Santo António, Porto, Portugal
               type:PostalAddress
            type:Organization
      name:Teresa Coelho
      affiliation:
            name:Centro Hospitalar Do Porto
            address:
               name:Centro Hospitalar Do Porto, Porto, Portugal
               type:PostalAddress
            type:Organization
      name:Morie A. Gertz
      affiliation:
            name:Mayo Clinic
            address:
               name:Mayo Clinic, Rochester, USA
               type:PostalAddress
            type:Organization
      name:Julian D. Gillmore
      affiliation:
            name:University College London
            address:
               name:National Amyloidosis Centre, University College London, London, UK
               type:PostalAddress
            type:Organization
      name:Philip N. Hawkins
      affiliation:
            name:University College London
            address:
               name:National Amyloidosis Centre, University College London, London, UK
               type:PostalAddress
            type:Organization
      name:Isabelle Lousada
      affiliation:
            name:Amyloidosis Research Consortium
            address:
               name:Amyloidosis Research Consortium, Boston, USA
               type:PostalAddress
            type:Organization
      name:Ole B. Suhr
      affiliation:
            name:Umeå University
            address:
               name:Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden
               type:PostalAddress
            type:Organization
      name:Giampaolo Merlini
      affiliation:
            name:IRCCS Policlinico San Matteo
            address:
               name:Amyloidosis Center Foundation, IRCCS Policlinico San Matteo, San Matteo, Italy
               type:PostalAddress
            type:Organization
            name:University of Pavia
            address:
               name:Department of Molecular Medicine, University of Pavia, Pavia, Italy
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Neurology, French National Reference Centre for Familial Amyloidotic Polyneuropathy, CHU Bicêtre, Université Paris-Saclay APHP, INSERM U1195, Le Kremlin-Bicêtre, France
      name:Department of Neurology, Graduate School of Medical Sciences, Kumamoto, Japan
      name:Ophthalmology Service, Hospital de Santo António, Porto, Portugal
      name:Centro Hospitalar Do Porto, Porto, Portugal
      name:Mayo Clinic, Rochester, USA
      name:National Amyloidosis Centre, University College London, London, UK
      name:National Amyloidosis Centre, University College London, London, UK
      name:Amyloidosis Research Consortium, Boston, USA
      name:Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden
      name:Amyloidosis Center Foundation, IRCCS Policlinico San Matteo, San Matteo, Italy
      name:Department of Molecular Medicine, University of Pavia, Pavia, Italy

External Links {🔗}(241)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.64s.

LINK . SPRINGER . COM {}